FDA goes union
This article was originally published in The Gray Sheet
Executive Summary
Review times should not be affected by the decision of FDA's non-supervisory employees in April to form two collective bargaining units, Susan Alpert, director of the agency's Office of Device Evaluation, says at a recent Food and Drug Law Institute meeting in Washington, D.C. As a result of the vote, FDA has entered into a memorandum of understanding with the National Treasury Employees Union. In addition to supervisors and administrative employees who handle personnel issues, the agreement excludes Public Health Service officers, of which 112 of FDA's 350 officers work in the Center for Devices and Radiological Health. A contract between FDA and NTEU has yet to be negotiated, according to agency staffers
You may also be interested in...
Respiratory Device Hand-off To FDA Dental Group Intended To Achieve Parity
Responsibility for reviewing respiratory device-related premarket submissions is expected to be transferred out of FDA's Division of Cardiovascular and Respiratory Devices (DCRD) to the Division of Dental, Infection Control and General Hospital Use Devices (DDIGD).
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”